Patient Safety & Systems-Based Practice

Transitions of care: SNF, home, hospice

Clinical Overview and When to Suspect Care Transition Failure

— ~20% of Medicare patients discharged from hospital are readmitted within 30 days; nearly half are preventable

— ~40% of patients have pending labs/studies at discharge; <25% of outpatient clinicians are aware

— Medication discrepancies occur in 50%+ of discharges; ~20% cause adverse drug events within 30 days

— Patient returns to ED within 72 hours of discharge with same or related complaint

— Caregiver unable to articulate medication regimen, red flags, or follow-up plan

— No PCP contact within 7–14 days post-discharge for high-risk conditions (CHF, COPD, post-MI, post-stroke)

— Polypharmacy (≥5 meds), low health literacy, lives alone, cognitive impairment, prior readmission, depression, substance use — all elevate risk

— Home: independent ADLs/IADLs or family support; needs PCP follow-up, med rec, teach-back

— SNF (Medicare Part A): requires 3-night qualifying inpatient stay (not observation) AND skilled need (PT/OT, wound care, IV abx); up to 100 days, day 1–20 fully covered, day 21–100 with copay

— Hospice (Medicare Part A): physician certification of prognosis ≤6 months if disease runs natural course; patient elects comfort-focused care, forgoes curative therapy for the terminal diagnosis

Step 3 management: On every discharge vignette, ask three questions: Where is the patient going? Who is following up and when? What could go wrong in the first 72 hours? These map directly to the most-tested answer choices.

Board pearl: "Observation status" does NOT count toward the 3-midnight rule for SNF coverage — a classic Step 3 trap.

Transitions of care (TOC) = movement of a patient between care settings (hospital → home, hospital → skilled nursing facility [SNF], home → hospice, SNF → hospital). Each handoff is a high-risk node for medication errors, missed diagnoses, and readmission.

Epidemiology of failure:

When to suspect a failing transition:

Three destination pathways tested on Step 3:

Presentation Patterns and Key History

— Elderly patient discharged on new anticoagulant returns with GI bleed → med reconciliation failure

— CHF patient readmitted in 2 weeks with volume overload → no scale at home, no early follow-up, diuretic dose error

— Post-op hip fracture patient at SNF develops delirium → benzodiazepine restart, UTI, or opioid accumulation

— Stage IV cancer patient with uncontrolled pain on home hospice → caregiver burnout, missed PRN escalation

— Patient discharged to "home with home health" but lives alone with dementia → unsafe disposition

— Functional status: ADLs (bathing, dressing, toileting, transfers, feeding, continence), IADLs (meds, money, meals, transportation, phone, shopping)

— Cognitive screen: Mini-Cog or MoCA if any concern; affects med self-administration and consent capacity

— Social context: lives alone vs with caregiver, stairs, bathroom access, food security, transportation to follow-up

— Financial/insurance: Medicare vs Medicaid vs commercial vs uninsured drives SNF/hospice eligibility and home-health benefit

— Goals of care: code status, prior advance directive, surrogate decision-maker, MOLST/POLST in many states

— Exact medications given at SNF in last 48 h (request the MAR)

— New symptoms timeline relative to medication changes

— Vaccination, recent procedures, falls, restraint use, antibiotic exposure (C. difficile risk)

Key distinction: Home health = intermittent skilled nursing/PT visits in the home, requires homebound status, covered by Medicare Part A. Home hospice = comfort-focused team (RN, SW, chaplain, aide, MD) for terminal prognosis ≤6 months, covered by Medicare hospice benefit. Custodial care (long-term nursing home) is generally NOT Medicare-covered — paid out of pocket or by Medicaid after spend-down.

Board pearl: When the stem says "patient cannot manage own medications and lives alone with mild dementia," the safe disposition is usually NOT home alone — expect SNF, assisted living, or home with 24-hour caregiver as the right answer.

Vignette archetypes to recognize:

Key history at the discharge encounter:

For readmission/SNF-to-ED transfers, ask:

Physical Exam Findings and Functional/Hemodynamic Assessment

— Vitals stable ≥24 h: afebrile, off pressors, off supplemental O₂ for ≥24 h (or stable on home O₂), HR/BP at baseline

— Ambulation: can the patient walk to the bathroom, use stairs if home has them, transfer safely? PT/OT clearance is often the rate-limiting step

— Mental status: at baseline per family; screen for hypoactive delirium (commonly missed) with attention testing (months backward, days backward)

— Pain control on oral regimen — IV-to-PO conversion documented and tolerated ≥24 h

— Tolerating diet and voiding/stooling appropriately

— Wound/line assessment: any drains, central lines, PICCs require home-health teaching or SNF

— Orthostatic drop ≥20/10 mmHg (fall risk, especially with new antihypertensives or diuretics)

— Resting tachycardia >100 unexplained

— Persistent O₂ requirement >2 L without home O₂ arranged

— Unstable glucose (frequent <70 or >300)

— Home alone: independent or near-independent ADLs, safe gait, intact cognition for meds

— Home with help: needs supervision/assist for 1–2 ADLs, caregiver available

— SNF: needs skilled rehab (e.g., post-CVA, post-hip ORIF) OR skilled nursing (IV abx, complex wound) AND will benefit and progress

— Long-term care: custodial needs without rehab potential

— Hospice (home or inpatient): symptom burden + terminal prognosis

CCS pearl: Before clicking "discharge" on a CCS case, always order PT/OT evaluation, case management/social work consult, and medication reconciliation if the patient has been inpatient >48 hours or is elderly. Missing these costs points.

Board pearl: A patient who fails a "stairs test" with PT cannot safely go home to a 2nd-floor apartment — SNF or stair-free housing is the answer.

Transitions of care is a systems topic, but Step 3 still tests the bedside assessment that drives disposition.

Pre-discharge "is this patient ready?" exam:

Hemodynamic red flags that should delay discharge:

Functional benchmarks for destination:

Diagnostic Workup — Pre-Discharge Checklist and Risk Tools

— Pending labs/cultures/imaging: explicitly documented with who will follow up and when (e.g., "blood cultures pending, PCP Dr. X will check on day 3")

— Trending vitals/labs: Hgb stable, Cr at baseline or new baseline acknowledged, INR therapeutic if on warfarin, K/Mg repleted if on diuretics

— Medication reconciliation: pre-admission list vs inpatient list vs discharge list, with explicit reason for every change

— Vaccinations: influenza, pneumococcal, COVID, Tdap, zoster, RSV per age/risk — discharge is a capture opportunity

— LACE index (Length of stay, Acuity, Comorbidity [Charlson], ED visits in last 6 mo) — predicts 30-day readmission/death; score ≥10 = high risk

— HOSPITAL score — similar purpose, includes Hgb, oncology, Na, procedure, admission type, prior admits, LOS

— Mini-Cog / MoCA — cognitive readiness for self-care

— Morse Fall Scale / Hendrich II — fall risk, especially for SNF placement

— PHQ-2/PHQ-9 — depression screening, drives readmission risk in CHF/post-MI

— CHF: dry weight documented, euvolemic exam, BNP trend, diuretic dose finalized

— COPD: off nebs ≥24 h on inhalers, inhaler technique observed, smoking cessation addressed

— Post-MI: dual antiplatelet started, statin, beta-blocker, ACEI/ARB, cardiac rehab referral

— Stroke: dysphagia screen passed, antithrombotic chosen, LDL <70 plan, BP regimen

— Diabetes: A1c known, insulin teaching done if new, glucometer + strips arranged

Step 3 management: When a question lists pending blood cultures or a pending biopsy at discharge, the correct next step is almost always "document responsible clinician and explicit follow-up plan" — not "wait for results before discharge."

Board pearl: The single most-tested cause of post-discharge ADE is medication discrepancy — reconciled list given to patient AND sent to outpatient pharmacy/PCP is the protective intervention.

Transitions don't have "labs," but Step 3 tests a structured pre-discharge diagnostic and readiness workup.

Mandatory pre-discharge data review:

Risk-stratification tools (know by name):

Disease-specific pre-discharge metrics:

Advanced Tools — Med Reconciliation, Teach-Back, and Care Coordination Models

— Compare pre-admission, inpatient, and discharge regimens at every transition

— Reconcile dose, route, frequency, indication, and duration

— Explicitly stop home meds that are unsafe (e.g., metformin held for AKI — restart? when?)

— Provide a single, plain-language list to the patient AND transmit to receiving clinician/SNF/pharmacy

— Ask the patient to explain in their own words: their diagnosis, each medication's purpose, red flags requiring call/return, and follow-up plan

— Re-teach gaps; repeat until correct. Recommended for every discharge, mandatory for low health literacy

— Project RED (Re-Engineered Discharge) — 11-component bundle; reduces readmission ~30%

— Care Transitions Intervention (Coleman model) — transitions coach, 4 pillars: medication self-management, personal health record, follow-up, red flags

— Transitional Care Model (Naylor) — APRN-led, intensive home follow-up for elderly with CHF

— BOOST (Better Outcomes by Optimizing Safe Transitions) — SHM toolkit, "8P" risk assessment

— Discharge summary to PCP within 24–48 hours (ideally before first follow-up visit) including: diagnoses, procedures, meds with changes, pending tests, follow-up appointments, code status, functional status

— Warm handoff (phone call) for high-risk patients or transfers to SNF

CCS pearl: On a CCS case ending in discharge, order "discharge instructions, medication reconciliation, follow-up appointment with PCP in 7–14 days" as discrete actions. For CHF/COPD/MI, 7 days; routine, 2 weeks.

Board pearl: A faxed discharge summary alone is insufficient for a complex SNF transfer — direct clinician-to-clinician handoff is the highest-yield safety intervention.

Formal medication reconciliation (Joint Commission NPSG.03.06.01):

Teach-back method (closes the loop on comprehension):

Evidence-based TOC models (recognize by name):

Information transfer requirements:

SNF transfer packet: must include H&P, discharge summary, full med list with last doses, code status/advance directive, recent vitals, isolation status (MRSA, VRE, C. diff, COVID), wound care orders, PT/OT recommendations

Risk Stratification — Choosing the Right Destination

— Step 1: Does the patient have terminal illness with prognosis ≤6 months and goals consistent with comfort? → Hospice (home, inpatient, or SNF-based)

— Step 2: Does the patient need skilled rehab or skilled nursing daily, AND had a ≥3-midnight inpatient stay? → SNF

— Step 3: Can the patient (with available caregivers and home health if needed) safely manage at home? → Home ± home health

— Step 4: If none of the above and patient cannot live independently → assisted living or long-term custodial care (Medicaid or private pay)

— Skilled need: PT/OT ≥5 days/week, IV antibiotics, complex wound care, new tube feeding, post-op rehab

— Reasonable expectation of improvement (Medicare no longer requires improvement standard after Jiménez v. Sebelius — maintenance therapy covered, but skilled need must persist)

— Patient/family agreement

— Homebound (leaving home requires considerable effort)

— Needs intermittent skilled care (nursing, PT, OT, ST, MSW)

— Under a physician's plan of care, face-to-face encounter within 90 days before or 30 days after start

— Two physicians (attending + hospice MD) certify prognosis ≤6 months

— Patient/surrogate elects hospice benefit, forgoes curative therapy for terminal diagnosis (can still treat unrelated conditions, e.g., a UTI in an end-stage cancer patient)

— Benefit periods: 90 + 90 + unlimited 60-day periods with face-to-face recertification

— Patient on observation status (not inpatient) → does NOT qualify for SNF Part A

— Patient needs custodial care only (help with ADLs, no skilled need) → SNF is NOT appropriate; consider assisted living or long-term care

— Patient wants curative chemo AND hospice → cannot elect hospice for that cancer (palliative care consult instead)

Key distinction: Palliative care = symptom-focused care at ANY stage of serious illness, concurrent with curative treatment. Hospice = palliative care for prognosis ≤6 months, curative intent abandoned.

Board pearl: "Concurrent care" exception — pediatric hospice patients (<21) under Medicaid/CHIP CAN receive curative and hospice care simultaneously (ACA provision).

Decision algorithm (high-yield for Step 3):

SNF appropriateness criteria:

Home health eligibility:

Hospice eligibility:

Common Step 3 traps:

Pharmacotherapy at Transitions — Med Rec and High-Risk Drug Classes

— Anticoagulants (warfarin, DOACs, LMWH) — bleeding, INR follow-up, drug interactions; ensure bridging plan if applicable

— Insulin and oral hypoglycemics — hypoglycemia if appetite/PO intake drops; "sliding scale only" regimens are inadequate long-term

— Opioids — constipation, sedation, respiratory depression; always co-prescribe bowel regimen; naloxone for high-dose or concurrent benzo

— Diuretics — electrolyte derangement, AKI, orthostasis; need follow-up BMP within 1–2 weeks

— Antibiotics — completion duration, C. diff risk, IV-to-PO transition

— Antiepileptics, lithium, digoxin, methotrexate — narrow therapeutic index

— Benzodiazepines and Z-drugs — restarted in elderly post-hospital cause falls and delirium; deprescribe

— Avoid: benzodiazepines, first-gen antihistamines (diphenhydramine), tertiary TCAs (amitriptyline), muscle relaxants, sliding-scale insulin alone, glyburide, NSAIDs chronic, anticholinergics

— PPI without ongoing indication

— Statin in advanced dementia/limited life expectancy

— Antihypertensives if persistently hypotensive

— Anticholinergic burden in cognitive impairment

— Prior authorization, formulary, copay — pick covered alternative when possible (e.g., apixaban vs warfarin if patient cannot afford)

— 30-day supply at discharge or "meds-to-beds" program reduces readmission

Step 3 management: For any elderly patient discharged on a new opioid, new anticoagulant, or new insulin, the correct answer includes early follow-up (≤7 days), explicit teaching, and a safety co-prescription (bowel regimen, INR plan, glucometer).

Board pearl: Restarting a home benzodiazepine "because the patient was on it before" is a Beers violation and a Step 3 wrong answer — taper, don't reflexively continue.

The single most dangerous moment for an elderly patient is the 30 days after discharge, largely driven by medications.

High-alert drug classes at transitions (memorize):

Beers Criteria (potentially inappropriate meds in adults ≥65):

STOPP/START criteria — European tool, similar concept; START reminds you of underused beneficial meds (e.g., statin in diabetic with CV disease, ACEI in CHF)

Deprescribing at transitions — discharge is the ideal moment:

Medication access barriers:

Procedures of Care Transition — Hospice Election, SNF Placement, Home Health Orders

— Two-physician certification (attending + hospice medical director) of prognosis ≤6 months

— Signed hospice election form by patient or healthcare surrogate

— Patient revokes Medicare benefits for curative treatment of the terminal diagnosis (can revoke hospice at any time and resume curative care)

— Four levels of hospice care: routine home care (most common), continuous home care (crisis symptom management, ≥8 h/day skilled care), inpatient respite (up to 5 days to relieve caregiver), general inpatient (uncontrolled symptoms requiring inpatient unit)

— Case management identifies SNF need; social work coordinates bed search

— Insurance authorization (Medicare Part A 3-midnight rule, or Medicare Advantage prior auth — often waives 3-midnight)

— Transfer packet: discharge summary, med list, code status, advance directives, recent vitals, infection precautions, PT/OT eval, DME orders, wound care plan

— Physician orders required for medications, diet, activity, therapy, restraints (rarely), DNR status — SNF cannot give a med without a physician order

— Physician (MD/DO/NP/PA) face-to-face encounter within 90 days before or 30 days after start of care

— Plan of care (CMS-485) signed by physician with frequency/duration of nursing, PT, OT, ST, MSW, aide

— Recertification every 60 days

— Hospital bed, oxygen, walker/wheelchair, commode, nebulizer, glucometer, CPAP — require physician order with medical necessity documentation; Medicare covers under Part B

CCS pearl: On a CCS hospice case, order: "hospice consult, palliative care consult, opioid + bowel regimen, anti-emetic PRN, family meeting/goals of care discussion, DNR order, social work." Do NOT order routine labs, telemetry, or DVT prophylaxis if goals are comfort-only.

Board pearl: Inpatient hospice level is the right answer for uncontrolled pain, intractable nausea/vomiting, or terminal agitation that cannot be managed at home — not just "imminent death."

Transitions of care is "proceduralized" through paperwork and orders that Step 3 expects you to know.

Hospice election procedure:

SNF placement workflow:

Home health start of care:

Durable medical equipment (DME) at discharge:

Special Populations — Elderly and Renal/Hepatic Impairment

— Polypharmacy (≥5 meds) baseline; hyperpolypharmacy (≥10) in 40% of nursing home residents

— Atypical presentations: delirium instead of fever in infection, confusion instead of dyspnea in PE, falls as a chief complaint masking syncope/MI/sepsis

— Sensory impairment: vision, hearing — affects med adherence and teach-back

— Cognitive impairment: screen with Mini-Cog; if positive, capacity assessment for discharge consent; involve surrogate

— Falls: Tinetti or Timed Up & Go; home safety eval (rugs, lighting, grab bars) via OT

— Frailty (Fried phenotype, Clinical Frailty Scale) predicts post-discharge mortality more than age

— DOACs: apixaban and rivaroxaban have specific renal cutoffs; dabigatran avoid CrCl <30

— LMWH (enoxaparin): reduce to 1 mg/kg daily if CrCl <30

— Gabapentin/pregabalin: dose-reduce; risk of sedation and falls

— Metformin: avoid if eGFR <30, dose-reduce 30–45

— Antibiotics: vancomycin, aminoglycosides, fluoroquinolones, β-lactams — renal dosing

— Digoxin: renal clearance; toxicity in AKI

— Avoid/dose-reduce: acetaminophen (cap 2 g/day in advanced cirrhosis), benzodiazepines (use lorazepam, oxazepam, temazepam — no hepatic metabolism), opioids (start low), statins (caution in active liver disease), NSAIDs (avoid in cirrhosis — bleeding, HRS)

— Brown bag review at first follow-up

— Match each med to an active indication; deprescribe orphans

— Simplify dosing (once-daily preferred); combination pills where appropriate

Step 3 management: For any elderly patient with cognitive impairment going home, the right answer typically bundles: caregiver-administered pillbox, weekly fill, home health nursing for med teaching, follow-up in 7 days, and capacity-assessed code status discussion.

Board pearl: Delirium at discharge is a contraindication to going home alone — extend stay, treat underlying cause, or transition to SNF/family caregiver until resolution.

Elderly (≥65) — the prototypical Step 3 TOC patient:

Renal impairment dose adjustments at discharge — high-yield drugs:

Hepatic impairment:

Polypharmacy reduction at discharge:

Special Populations — Pediatrics, Pregnancy, and Behavioral Health Transitions

— Newborn discharge: ≥48 h vaginal, ≥96 h C-section recommended; bilirubin check, weight, feeding, voiding/stooling documented; follow-up within 48–72 h of discharge

— Hospital-to-home for chronic conditions (asthma, T1DM, sickle cell): teach-back with caregiver, asthma action plan, glucagon kit, hydroxyurea adherence

— Pediatric concurrent hospice care (ACA section 2302): children <21 on Medicaid/CHIP can receive both curative and hospice care simultaneously

— Transition from pediatric to adult care: start at 12–14, complete by 18–21; structured handoff for chronic conditions (sickle cell, CF, congenital heart disease, T1DM, IBD); high-risk period for loss to follow-up

— Postpartum visit: comprehensive visit by 12 weeks, plus an early contact within 3 weeks (ACOG updated recommendation — not the old single 6-week visit)

— Screen for postpartum depression (Edinburgh), HTN/preeclampsia signs, breastfeeding, contraception

— Postpartum VTE risk elevated 6 weeks — prophylaxis if high-risk

— Gestational diabetes: 75-g OGTT at 4–12 weeks postpartum; lifetime T2DM screening every 1–3 years

— Post–psychiatric hospitalization follow-up within 7 days (HEDIS quality measure); 30-day measure also tracked

— Suicide-risk patients: safety planning, lethal means restriction (firearms, meds), warm handoff to outpatient provider, crisis line, follow-up call within 24–72 h

— Substance use disorder: link to MAT (buprenorphine, methadone, naltrexone) before discharge; opioid overdose survivors should leave with naloxone

— Avoid abrupt benzodiazepine discontinuation in long-term users — taper plan

— Medical respite programs, shelter coordination, Medicaid enrollment assistance, 30-day med supply, accessible follow-up site (FQHC)

Key distinction: "Discharge to shelter" without coordinated medical respite is a known patient safety failure — Step 3 favors medical respite placement for homeless patients needing recovery.

Board pearl: Post-psychiatric discharge follow-up within 7 days is a board-favorite quality metric — pair it with safety planning and means restriction.

Pediatric transitions:

Pregnancy and postpartum transitions:

Behavioral health transitions (HIGH readmission risk):

Homeless/uninsured patients:

Complications and Adverse Outcomes of Failed Transitions

— ~20% of Medicare patients readmitted within 30 days; CMS Hospital Readmissions Reduction Program (HRRP) penalizes hospitals for excess readmissions in AMI, CHF, pneumonia, COPD, CABG, elective THA/TKA

— Top drivers: medication errors, missed follow-up, inadequate patient/caregiver education, premature discharge

— Occur in ~20% of patients within 3 weeks of discharge

— Most common: anticoagulant bleeding, hypoglycemia, opioid-related events (sedation, constipation, falls), diuretic-induced AKI/electrolytes

— One-third are preventable, another third ameliorable

— Pending tests not followed up (cultures growing, biopsy returning malignant, incidentalomas)

— "I thought you were following up on that" — closed-loop communication failure

— Hospital-associated deconditioning, especially in elderly; one-third of older patients discharged with new ADL deficit

— Early mobilization and rehab placement mitigate

— C. difficile post-antibiotic; MRSA/VRE colonization carried to SNF; CAUTI/CLABSI from indwelling devices

— SNF must be notified of isolation status at transfer

— 14% of older adults; orthostasis from new meds, deconditioning, unfamiliar new equipment

— Anxiety, depression, sleep deprivation; predicts hospice revocation and ED visits

— Respite care (Medicare hospice benefit covers 5 days of inpatient respite per benefit period)

— Unexpected SNF copays (day 21+), medication costs, transportation — drives non-adherence

Step 3 management: When a vignette describes a readmission within 30 days, the highest-yield answer is usually a process intervention (early follow-up call, med rec, home health) rather than a new diagnostic test.

Board pearl: A patient returning to ED 5 days post-discharge with hypoglycemia almost always has had a medication discrepancy — full insulin regimen continued without adjustment for reduced PO intake.

Readmission:

Adverse drug events (ADEs):

Diagnostic errors at handoff:

Functional decline:

Healthcare-associated infections crossing settings:

Falls in first 30 days post-discharge:

Caregiver burnout in hospice/home settings:

Financial toxicity:

When to Escalate — Inpatient Triage from SNF, Home, or Hospice

— Sepsis (qSOFA ≥2, hypotension, lactate, new organ dysfunction)

— Acute stroke, STEMI/unstable angina, GI bleed with instability

— Acute abdomen, bowel obstruction

— Respiratory failure not manageable with SNF resources

— Hip fracture, significant trauma

— Acute psychiatric emergency

— Mild UTI, low-grade dehydration, mild CHF exacerbation if SNF has IV diuretics and monitoring

— INTERACT (Interventions to Reduce Acute Care Transfers) tools help SNF staff manage in place

— Always check goals of care and code status before transfer — many SNF residents have DNR/DNH (Do Not Hospitalize) orders that should be honored

— Red flags: chest pain, focal neuro deficits, syncope, severe dyspnea, GI bleed, suicidal ideation with plan, sepsis criteria

— Subacute: same-day or next-day office/urgent care for non-emergent escalation (worsening CHF, COPD, cellulitis, glycemic instability)

— Hospice is NOT "no care" — escalate within the hospice framework: continuous home care for crisis symptoms, general inpatient hospice level for refractory symptoms

— Revoking hospice is appropriate only if patient/family changes goals to curative care

— Common error: family panics and calls 911, patient gets aggressive resuscitation despite DNR — prevent with anticipatory guidance, written DNR/POLST in the home, hospice 24/7 phone line

— Every discharge should include a number to call before going to ED

— Post-discharge follow-up phone call within 48–72 h reduces readmission

CCS pearl: On a CCS hospice case where family calls about agitation, the right move is hospice nurse home visit + haloperidol or lorazepam, not ED transfer. Always re-confirm goals.

Board pearl: A POLST/MOLST is a portable physician order that travels with the patient across settings (home, EMS, SNF, hospital) — superior to an advance directive alone for honoring DNR in the field.

From SNF to hospital — appropriate transfers:

From SNF — situations where transfer is often AVOIDABLE with proper SNF management:

From home — when to send to ED vs office:

From hospice — escalation paradox:

Telephone triage at transitions:

Key Differentials — Same-Category Disposition Decisions

— IRF: patient can tolerate ≥3 hours of therapy/day, 5 days/week; physician-led, RN 24/7; conditions like stroke, SCI, TBI, major multi-trauma, amputation, complex orthopedic

— SNF: patient tolerates 1–2 hours therapy/day; lower intensity; broader population (deconditioning, post-op, IV abx)

— LTACH: medically complex, average LOS >25 days, vent weaning, complex wound, multi-system illness; hospital-level care

— SNF: lower acuity

— Home health: homebound + skilled need; intermittent

— Outpatient PT/OT: not homebound, can travel; more intensive therapy options

— Assisted living: ADL support, social, meals; not Medicare-covered; private pay or Medicaid waiver

— SNF (custodial level): 24-h nursing supervision; covered by Medicaid after spend-down, not Medicare for long-term

— Palliative care: any stage, concurrent with curative; consultation service

— Hospice: ≤6 month prognosis, election forgoes curative for terminal dx

— Home hospice (routine): symptom-managed at home, family/caregiver delivers most care

— General inpatient (GIP) hospice: uncontrolled symptoms requiring inpatient management; short-term, not for custodial reasons

— Respite inpatient: caregiver relief, up to 5 consecutive days

Key distinction: A patient who can tolerate 3 hours of therapy daily and has stroke or hip fracture is an IRF candidate — choosing SNF is suboptimal on the boards if IRF is offered.

Board pearl: "Patient wants to die at home with family but pain is uncontrolled" — answer is general inpatient hospice for symptom control, then transition back to home hospice when stable.

Step 3 frequently asks you to distinguish among similar dispositions. Master these contrasts:

SNF vs Inpatient Rehabilitation Facility (IRF / "acute rehab"):

SNF vs Long-Term Acute Care Hospital (LTACH):

Home health vs outpatient therapy:

Assisted living vs SNF (custodial vs skilled):

Hospice vs palliative care:

Home hospice vs inpatient hospice unit:

Key Differentials — Insurance and Regulatory "Look-Alikes"

— Part A: inpatient hospital, SNF (after 3-midnight stay), home health, hospice

— Part B: outpatient physician services, DME, outpatient therapy, some home infusion

— Part D: outpatient prescription drugs

— Part C (Medicare Advantage): private plans bundling A+B (often D); may waive the 3-midnight rule for SNF and require prior authorization

— Inpatient: "two-midnight rule" — physician expects ≥2 midnights of medically necessary care

— Observation: outpatient status, billed under Part B; does NOT count toward 3-midnight SNF qualification even if patient is in hospital bed for 3 nights

— Patients must receive a MOON (Medicare Outpatient Observation Notice) if observation >24 h

— Medicare does NOT cover long-term custodial nursing home care

— Medicaid covers long-term care after asset spend-down to state limits; primary payer for ~60% of nursing home residents

— Covers: nursing, MD, SW, chaplain, aide, meds related to terminal dx, DME, bereavement

— Does NOT cover: room and board in a SNF/nursing home (custodial cost still patient's responsibility unless Medicaid pays)

— HRRP — readmission penalties

— HAC Reduction Program — hospital-acquired conditions

— Value-Based Purchasing — outcomes, patient experience

— SNF VBP — SNF readmission rate

— Bundled payments (BPCI, CJR) — 90-day episode payment; aligns incentives across hospital, SNF, home health

Step 3 management: When a patient cannot afford a recommended SNF stay because observation status disqualifies them, the correct answer often involves case management appeal, conversion to inpatient if criteria met, or alternative disposition with home health.

Board pearl: Hospice does NOT pay for nursing home room and board — a common family surprise. Medicaid or private funds cover the custodial cost.

Step 3 tests the insurance/regulatory framework because it dictates real-world disposition.

Medicare Part A vs Part B vs Part D vs Medicare Advantage (Part C):

Inpatient vs Observation status:

Medicaid vs Medicare for long-term care:

Medicare hospice benefit specifics:

CMS quality programs affecting transitions:

Secondary Prevention / Discharge Medications / Long-Term Plan

— Reconciled medication list with indication, dose, frequency, duration in plain language

— Written diagnosis summary, red flags, when to call/return

— Follow-up appointments scheduled (not "call to schedule") before discharge

— 24/7 callback number

— Vaccinations updated (flu, pneumococcal, COVID, RSV per age, Tdap, zoster)

— Post-MI: dual antiplatelet (ASA + P2Y12), high-intensity statin, beta-blocker, ACEI/ARB (if EF reduced, HTN, DM, CKD), aldosterone antagonist (if EF ≤40% + HF or DM), cardiac rehab referral, smoking cessation, BP <130/80, LDL <70 (often <55)

— CHF (HFrEF): GDMT = ARNI (or ACEI/ARB), beta-blocker, MRA, SGLT2i; loop diuretic PRN; daily weights; Na restriction; CHF clinic follow-up in 7 days

— Stroke/TIA: antiplatelet or anticoagulant (AF), high-intensity statin (LDL <70), BP <130/80, glycemic control, smoking cessation, carotid intervention if indicated

— COPD: inhaler bundle (LABA/LAMA ± ICS based on phenotype), smoking cessation, pulmonary rehab, vaccinations, action plan, oxygen if qualifying

— Diabetes: A1c goal individualized (typically <7%), statin per ASCVD risk, ACEI/ARB if albuminuria, SGLT2i if CV/renal disease, GLP-1 if obesity/CV, retinal/foot/renal screening

— VTE: anticoagulation 3 months (provoked) or indefinite (unprovoked, recurrent, cancer); reassess at 3 months

— Pneumonia: ensure clinical stability, confirm vaccine status, smoking cessation, 1-week follow-up

— Chronic care management billing (Medicare CCM, TCM codes 99495/99496 for 7- or 14-day post-discharge contact)

— Advance care planning revisited at each transition

— Caregiver support resources

Step 3 management: TCM (Transitional Care Management) — phone/electronic contact within 2 business days + face-to-face visit within 7 or 14 days depending on complexity — is the billable framework boards reward.

Board pearl: Every post-MI patient should leave with a cardiac rehab referral — a Class I recommendation underutilized in practice and a favorite Step 3 right-answer.

Universal discharge bundle (every patient):

Condition-specific secondary prevention (high-yield):

Long-term plan elements:

Follow-Up, Monitoring Parameters, and Rehab/Counseling

— CHF, COPD, AMI, stroke, pneumonia: PCP or specialty visit within 7 days

— Psychiatric admission: outpatient mental health within 7 days (HEDIS)

— Surgical procedures: wound check 7–14 days; suture removal as appropriate

— Routine medical: 14–30 days

— Hospice: RN visit within 48 hours of admission to hospice; recertification face-to-face by hospice physician at start of 3rd benefit period

— Home health: initial RN visit within 48 hours of hospital discharge

— SNF: physician visit required within 30 days of admission, then every 30 days first 90 days, every 60 days thereafter

— Diuretic start/change: BMP at 1–2 weeks

— ACEI/ARB/spironolactone start: BMP at 1–2 weeks (K, Cr)

— Statin: ALT only if symptomatic; lipid panel at 4–12 weeks

— Warfarin: INR every 2–4 days initially, then weekly, then monthly when stable

— New insulin: glucose log review at 1 week; A1c at 3 months

— Thyroid replacement: TSH at 6 weeks

— Cardiac rehab — post-MI, post-CABG, HFrEF, valve surgery, PAD

— Pulmonary rehab — moderate-to-severe COPD, post-COPD exacerbation

— Stroke rehab — PT/OT/ST coordinated

— Diabetes self-management education (DSME) — at diagnosis, annually, with complications

— Smoking cessation counseling + pharmacotherapy (varenicline, NRT, bupropion)

— Substance use treatment linkage with warm handoff

— Specific red flags for the condition

— Demonstrated medication administration

— Equipment use (CPAP, glucometer, insulin pen, nebulizer)

— Respite resources

CCS pearl: Always schedule the follow-up explicitly: "PCP follow-up in 7 days" — vague answers like "advise patient to follow up" lose points and reflect real-world failure.

Board pearl: Post-discharge follow-up phone calls and TCM visits are billable, reimbursed, and reduce readmission — one of the highest-yield "what should we do" answers.

Follow-up timing benchmarks (memorize):

Post-discharge phone call within 48–72 h (nurse or pharmacist) — reduces readmission ~15–25%; verifies meds, symptoms, follow-up

Disease-specific monitoring labs at follow-up:

Rehab and counseling referrals:

Caregiver counseling:

Ethical, Legal, and Patient Safety Considerations

— Decision-making capacity is decision-specific and assessed by treating clinician (not always psychiatry): patient must understand, appreciate, reason, and express a choice

— If capacity lacking → activate surrogate hierarchy (per state law, typically spouse → adult child → parent → sibling) or court-appointed guardian

— A patient with capacity may refuse SNF placement even against medical advice — document discussion of risks, alternatives, AMA process

— Advance directive (living will, healthcare proxy) — patient-completed

— POLST/MOLST — physician orders based on advance directive, portable across settings (home, EMS, SNF, hospital)

— Always transmit code status with the patient at every transfer — a documented Joint Commission failure when missing

— Elder abuse/neglect — most states require physician report to Adult Protective Services on reasonable suspicion, not proof

— Child abuse — mandatory in all states

— Unsafe discharge to suspected abusive environment requires APS/CPS contact before discharge

— A SNF/hospice cannot refuse to accept a transfer for discriminatory reasons; hospital cannot discharge an unstable patient

— Insurance status does not change EMTALA obligations

— Patient may revoke hospice at any time

— Aggressive symptom control (e.g., opioids titrated to relieve dyspnea) is ethically appropriate even if it may hasten death — doctrine of double effect

— Voluntarily stopping eating and drinking (VSED) is legally permitted in capacitated patients

— Medical aid in dying — legal in some states with strict criteria; differs from euthanasia; not required of any physician

— Communication failures at handoff are the #1 root cause of preventable harm

— Read-back, structured handoff (I-PASS, SBAR), warm handoff for high-risk patients

Step 3 management: A capacitated patient refusing SNF and insisting on going home alone — even unsafely — has the right to refuse; the correct answer is to document capacity, educate on risks, arrange maximum home support, and provide follow-up, NOT to seek emergency guardianship reflexively.

Board pearl: If a stem describes an elderly patient with new bruises and a hesitant caregiver, the right answer at discharge is report to Adult Protective Services, regardless of whether abuse is confirmed.

Capacity and consent at transitions:

Advance directives, MOLST/POLST, and DNR portability:

Mandatory reporting at transitions:

Patient dumping (EMTALA implications):

Hospice-specific ethical issues:

Transition-of-care safety failures (Joint Commission top causes of sentinel events):

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: When a vignette mentions "observation status for 3 nights, now needs rehab" — the trap answer is SNF; the right answer is home with home health or self-pay rehab because SNF coverage is not triggered.

3-midnight rule — Medicare Part A SNF qualification requires 3 consecutive inpatient midnights (observation excluded). Medicare Advantage may waive.

SNF coverage: Days 1–20 fully covered; days 21–100 daily copay (~$200+); after day 100, patient pays full cost.

Hospice prognosis criterion: ≤6 months if disease runs natural course; recertified every benefit period.

Hospice levels: routine home, continuous home, inpatient respite (5 days max), general inpatient.

Concurrent pediatric hospice: ACA Section 2302 — children <21 on Medicaid/CHIP can receive curative + hospice care simultaneously.

Top readmission diagnoses (HRRP): AMI, CHF, pneumonia, COPD, CABG, elective THA/TKA.

7-day follow-up benchmarks: CHF, COPD, MI, stroke, pneumonia, post-psychiatric admission.

LACE index components: Length of stay, Acuity, Comorbidity (Charlson), ED visits in last 6 months. Score ≥10 = high risk.

Beers Criteria avoid list (≥65): benzodiazepines, first-gen antihistamines, anticholinergics, sliding-scale-only insulin, glyburide, chronic NSAIDs, tertiary TCAs.

TCM CPT codes: 99495 (moderate complexity, 14-day visit) and 99496 (high complexity, 7-day visit) — require contact within 2 business days + face-to-face visit.

Medicare hospice does NOT pay for nursing home room and board — that is custodial cost.

Postpartum visit (ACOG): initial contact within 3 weeks, comprehensive by 12 weeks.

Newborn discharge: ≥48 h vaginal, ≥96 h C-section, follow-up 48–72 h after discharge.

POLST/MOLST is portable physician orders for life-sustaining treatment — travels across settings.

Double effect doctrine: appropriate symptom relief that may shorten life is ethically and legally permissible.

EMTALA governs ED stabilization and transfer; insurance status irrelevant.

Medicaid spend-down funds custodial nursing home care after assets depleted to state limits.

Home health requires homebound status + intermittent skilled need + face-to-face encounter.

Project RED, Coleman CTI, Naylor TCM, BOOST — named transition models reducing readmission.

Post-MI discharge bundle: ASA + P2Y12 + statin + beta-blocker + ACEI/ARB + cardiac rehab.

Board Question Stem Patterns

— Distinguish IRF (≥3 h/day therapy, complex) vs SNF (1–2 h/day) vs home with home health vs custodial care.

— Watch for: observation status (no SNF Part A), patient lives alone (home health insufficient if unsafe), prior functional baseline.

— Answer: hospice referral, goals-of-care conversation, palliative care consult — not more chemo or aggressive workup.

— Right answer: process intervention (early follow-up, med rec, home health, scale at home, dietary counseling) — not a new diagnostic test.

— Assess decision-specific capacity. If capacitated → respect autonomy, maximize home supports, document.

— Cannot continue curative chemo for terminal dx under Medicare hospice (except concurrent in pediatric Medicaid); offer palliative care if curative intent continues.

— Lesson: discharge summary transmission + closed-loop med rec + early follow-up.

— Right answer: honor DNH, treat in place with PO antibiotics/SQ fluids; reaffirm goals.

— Outpatient follow-up within 7 days, safety planning, lethal means restriction, naloxone if substance use.

— Explain rules; arrange home health or community resources.

— Document responsible clinician, communicate to PCP, document plan — do not delay discharge for stable patient.

Step 3 management: When two answer choices both seem reasonable, choose the one that explicitly closes the communication loop — that is the systems-based right answer.

Board pearl: "Re-admit the patient" is rarely the right answer if the issue can be addressed via outpatient escalation, home health, or telephone triage.

Pattern 1 — "Best disposition?" Elderly patient post-op or post-stroke, partially independent, needs ongoing therapy.

Pattern 2 — "Most appropriate next step in management?" Patient with metastatic cancer, ECOG declining, family wants comfort.

Pattern 3 — Readmission stem: CHF patient readmitted in 10 days with volume overload, no follow-up appointment, ran out of diuretic.

Pattern 4 — Capacity/refusal: Elderly patient with mild dementia refuses SNF, family wants placement.

Pattern 5 — Hospice eligibility: Patient with prognosis ≤6 months, family asks about chemotherapy continuation.

Pattern 6 — Medication reconciliation failure: Patient discharged on apixaban, returns with hematemesis 5 days later; outpatient PCP unaware.

Pattern 7 — SNF-to-ED transfer: SNF resident with DNR/DNH and dementia transferred for low-grade UTI/dehydration; family in distress.

Pattern 8 — Post-psychiatric discharge: Patient hospitalized for suicide attempt now stable.

Pattern 9 — Insurance/disposition mismatch: Observation status patient needs rehab; family expects SNF.

Pattern 10 — Pending test: Blood cultures pending at discharge.

One-Line Recap

Safe transitions of care = right destination + reconciled medications + closed-loop communication + timely follow-up + honored goals of care.

Board pearl: On any Step 3 transitions vignette, ask: Where, who, when, what could go wrong? — the answer choice that addresses the most of these four is almost always correct.

Destination logic: Hospice if prognosis ≤6 months and goals are comfort; SNF if 3-midnight inpatient stay + skilled need; home (± home health) if functionally safe; IRF if tolerates ≥3 h therapy daily for complex rehab. Custodial-only needs are not Medicare-covered.

Medication safety: Full med reconciliation at every transition, teach-back with patient and caregiver, special vigilance with anticoagulants, insulin, opioids, diuretics, and any Beers-criteria drug in the elderly; deprescribe at discharge when appropriate.

Communication: Discharge summary to receiving clinician within 24–48 hours, warm handoff for high-risk transfers, post-discharge phone call within 48–72 hours, follow-up appointment scheduled (not "to be scheduled") — 7 days for CHF/COPD/MI/stroke/pneumonia/psychiatric, 14 days for routine.

Ethics and safety: Decision-specific capacity assessment for refusal of disposition; portable POLST/MOLST travels with the patient; mandatory APS/CPS reporting for suspected abuse; respect double effect in hospice symptom management; never reflexively re-hospitalize a SNF resident with DNH orders — treat in place when feasible.